Lv11
66 积分 2021-12-29 加入
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient
3小时前
待确认
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non–small cell lung cancer
4小时前
已完结
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
8天前
已完结
ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor with Distinctive Genomic Characteristics
17天前
已完结
Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous
30天前
已完结
Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas
1个月前
已关闭
Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex
3个月前
已完结
Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex
3个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
3个月前
已完结
Fumarate hydratase-deficient renal cell carcinoma: a single institution-based study of 29 patients by clinicopathological, immunohistochemical and genetic approaches
5个月前
已完结
皖公网安备34019202002308
